Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03763747 · ClinicalTrials.gov registry record · NA
Scoreflex NC - Scoring PTCA Catheter
A NA study, sponsored by OrbusNeich.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT03763747 is a NA study that has completed, run by OrbusNeich. The registered enrollment target is 200 participants.
The verdict
NCT03763747, a NA study, has completed, sponsored by OrbusNeich.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
A prospective, open label, multi-center, single arm, observational study designed to evaluate the acute safety and device procedural success of the Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) catheters in subjects with stenotic coronary arteries during percutaneous coronary intervention. Two-hundred (200) subjects will be treated at up to 15 U.S. sites with the Scoreflex NC Scoring PTCA catheter during their index procedure. All subjects will be screened according to the protocol inclusion and exclusion criteria and will be followed through hospital discharge.
Interventions
- DEVICE Scoreflex NC Scoring PTCA catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-02-27 |
| Est. Completion | 2019-12-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03763747
The ClinicalTrials.gov registry entry for NCT03763747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OrbusNeich, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Scoreflex NC Scoring PTCA catheter is the first listed.
NCT03763747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03763747 about?
NCT03763747 is a clinical study titled "Scoreflex NC - Scoring PTCA Catheter". A prospective, open label, multi-center, single arm, observational study designed to evaluate the acute safety and device procedural success of the Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) catheters in subjects with stenotic coronary arteries during percutaneous cor...
What is the current status of trial NCT03763747?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2019-02-27. Estimated completion is 2019-12-27.
What interventions are being tested in trial NCT03763747?
The interventions under investigation include: Scoreflex NC Scoring PTCA catheter (DEVICE).
Who is sponsoring clinical trial NCT03763747?
This trial is sponsored by OrbusNeich, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.